Prevention and treatment of corneal graft rejection: current practice patterns (2004)

Cornea
J Bradley Randleman, R D Stulting

Abstract

This study was designed to analyze current practice patterns in the prevention and treatment of corneal graft rejection and to compare these patterns with previously reported practices. In January 2004, a survey addressing the routine postoperative management of corneal transplants and the treatment of various manifestations of corneal graft rejection was sent to members of The Cornea Society. Of the 396 surveys, 111 (28%) were returned and analyzed. All respondents used topical corticosteroids for routine postoperative management and treatment of endothelial graft rejection. Prednisolone, in brand or generic form, was used by 37 to 90% for routine management in various clinical scenarios and 81 to 91% for various manifestations of graft rejection at all time points; however, after 6 months, 12 to 26% used loteprednol etabonate for routine management. For routine management of high-risk grafts, 48% used topical cyclosporine in addition to prednisolone. Compared with previous surveys, the use of oral steroids significantly decreased for the routine management of high-risk corneal transplants, and the use of subconjunctival steroids decreased for the management of graft rejection. Topical prednisolone remains the mainstay for the...Continue Reading

References

Apr 1, 1989·Archives of Ophthalmology·P N Arrowsmith, R G Marks
May 15, 1989·American Journal of Ophthalmology·J C Hill
Aug 1, 1989·Ophthalmology·M W BelinJ Chmielinska
Jun 1, 1988·Ophthalmology·R D StultingH D Cavanagh
Feb 1, 1995·American Journal of Ophthalmology·J C Zhao, X Y Jin
Aug 26, 1998·Journal of Glaucoma·G D NovackM B Sherwood
Jul 29, 2000·Japanese Journal of Ophthalmology·K InoueM Araie
Mar 10, 2001·Ophthalmology·V BersudskyS Rumelt
Dec 6, 2001·The British Journal of Ophthalmology·A C PoonR J Buckley
Jan 24, 2002·Cornea·Patricia Aiken-O'Neill, Mark J Mannis
Apr 16, 2003·Eye & Contact Lens·C Banu CosarChristopher J Rapuano
Jun 27, 2003·Cornea·Daniel J WeisbrodAllan R Slomovic
Jul 20, 2004·The British Journal of Ophthalmology·N Al-YousufS M Daya

❮ Previous
Next ❯

Citations

Jul 20, 2007·International Ophthalmology·Khalid F Tabbara
Jan 16, 2008·International Ophthalmology·Francis W Price, Marianne O Price
Jun 6, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Jin YuanShi-you Zhou
Mar 15, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yannis AthanasiadisParwez Hossain
Nov 7, 2007·Transplantation·Keryn A Williams, Douglas J Coster
Feb 2, 2010·Cornea·Heather M Skeens, Edward J Holland
Aug 31, 2010·Cornea·Leonardo N SantosMiguel N Burnier
Mar 11, 2011·Cornea·Deepak Gupta, Chris Illingworth
Oct 23, 2013·Cornea·Machiko Shimmura-TomitaJun Shimazaki
Jul 9, 2010·International Ophthalmology Clinics·Maeve O'Doherty, Conor C Murphy
Sep 7, 2013·The British Journal of Ophthalmology·Otavio A MagalhaesSergio Kwitko
Sep 4, 2012·Clinical Ophthalmology·Richard Mh LeeChristopher Sc Liu
Oct 31, 2014·Cornea·Mohammed Ziaei, Bita Manzouri
Dec 29, 2007·Current Opinion in Ophthalmology·Samuel C YiuPho Nguyen
Jan 4, 2008·Expert Opinion on Drug Safety·Shahram Kashani, Ali A Mearza
Jun 3, 2009·Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye·Miguela IbáñezDelmy I Calderón
Apr 29, 2008·American Journal of Ophthalmology·Louis HoffartJohn Conrath
Oct 1, 2009·Clinical & Experimental Ophthalmology·Abdulgani AhmedSepici Aylin
Apr 21, 2011·Journal of Clinical Pharmacology·Ioannis AthanasiadisAnant Sharma
Mar 21, 2007·American Journal of Ophthalmology·Lucio Buratto, Elisabetta Böhm
Mar 20, 2012·Expert Opinion on Pharmacotherapy·Mohammed ZiaeiBita Manzouri
Aug 26, 2010·Ocular Immunology and Inflammation·Canan Asli UtineEsen K Akpek
Apr 8, 2014·Case Reports in Ophthalmological Medicine·Radoslaw RozyckiMarek Rekas
Jan 13, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Qing PanJustin Hanes
Sep 5, 2007·Anais Da Academia Brasileira De Ciências·Luiz F M Barros, Rubens Belfort
Jan 1, 2016·Vestnik oftalmologii·S V TrufanovD A Krakhmaleva
Aug 28, 2015·The Cochrane Database of Systematic Reviews·Minawaer AbudouXueyi Chen
Dec 21, 2019·Clinical & Experimental Ophthalmology·Adrian T FungPaul Beaumont
Nov 6, 2020·Clinical Ophthalmology·Omar M SaidAli Natag Riad Mostafa
Feb 27, 2021·Klinische Monatsblätter für Augenheilkunde·Sonja HeinzelmannThomas Reinhard
Mar 11, 2021·The British Journal of Ophthalmology·Rashmi DeshmukhHarminder Singh Dua
Apr 24, 2021·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Newton AndradeManoel Odorico de Moraes
Dec 31, 2017·Survey of Ophthalmology·Wei ZhongDimitri T Azar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.